Home
Inanovate Spotlight

The Inanovate website is presently undergoing an upgrade. Please come back later this week for full access to the new website content.

Inanovate launches the Bio-ID™ protein screening platform.

Image

The Bio-ID is a new generation of screening technology that provides users with accurate, highly sensitive kinetic data on multiple protein interaction in real-time. 

Click Here to learn more about the Bio-ID™ and how to access its benefits.
 

Inanovate's Mission

"To provide the Life Sciences industry with the world's leading technology for screening and analysing proteins."

To achieve this mission, Inanovate has developed a breakthrough approach to protein bioassays, known as the Bio-ID. The Bio-ID combines the benefits of labeled screening technologies (high sensitivity, throughput, and density), with the functional benefits of label free ones (real-time, kinetic data), and delivers them in a low cost, easy to use format.

The Bio-ID is a new category of protein screening technology that can play a key role in the development and implementation of next generation of diagnostics and therapeutics.

Products & Services

Companies interested in accessing the benefits of the Bio-ID to develop, sell and/or distribute bioassays, can do so via Inanovate's Bio-ID Licensing Program.

Companies, institutes or clinical centers interested in accessing the benefits of the Bio-ID for biomarker discovery and/or validation programs, can do so through Inanovate's Biomarker Alliance Program. 

Additional products and services designed to make protein research more accurate, reliable and cost effective include: High performance protein microarray surfaces; and a wide variety of protein micro-array Services including protein printing/arraying, and assay development.

Our History

In 2010 Inanovate begun the development of a novel approach to the detection and measurement of multiple proteins called Longitudinal Assay Screening (LAS). LAS was developed to help users in both research and clinical markets to accurately detect and measure multiple proteins from patient samples at virtually any concentration, without the need for multiple sample dilutions or complex preparations. Recently, Inanovate successfully completed testing and benchmarking the first platform to integrate LAS: The Bio-ID 400.

Read More

The Bio-ID (Dx)

A fully automated version of the Bio-ID is under development, to faciliate the detection and monitoring of disease related protein biomarkers at the point of care. This version of the Bio-ID (provisionally termed the Bio-ID (Dx)) is scheduled for completion in 2014, and is designed to move the healthcare industry’s focus away from expensive, painful and often ineffective late stage treatments, towards early stage diagnosis and lower impact, lower cost therapies. Initial clinical applicaitons of the Bio-ID (Dx) include the diagnosis and monitoring of prostate and ovarian cancer.

Read More

Microarray Slides (The i-Slide)

Using proprietary nano-scale surface modification technology, Inanovate has developed advanced surfaces for handling and working with proteins. The i-Slide™ is a premier surface for protein microarray experiments. It consists of a surface structured at the nano-scale to influence the density and orientation of proteins on the surface; helping optimize the proteins activity / responsiveness and enhance assay performance.

Read More

The Bio-ID 400

The Bio-ID 400 is the world's first platform to integrate Longitudinal Assay Screening. In direct comparison tests to leading competition, the Bio-ID has demonstrated over 10,000 fold improvements in dynamic range, 10 fold improvements in sensitivity, and 2 fold improvements in reproducibility on a range of multiplexed test assays. By enabling significant advances in the accuracy, complexity and cost of bioassays, the Bio-ID is set to play a leading role in the development and implementation of next generation diagnostics and therapeutics.

Read More

Services

Inanovate has extensive protein arraying capabilities, housing fully automated sample handling systems, multiple state of the art protein arrayers, and multiple array and well based scanning and analysis systems. Leveraging these facilities and our industry leading protein micro-array expertise, Inanovate offers custom protein printing / arraying services, as well as fully integrated assay development services and support. Please contact our enquiries team for further details.

Read more